The Study for Efficacy of Adalimumab Conbined Elemental Diet Therapy for Crohn's Disease
Not Applicable
Completed
- Conditions
- Crohn's Disease patient who was ineffective for present therapy and who has not been treated with anti TNF alpha antibody.
- Registration Number
- JPRN-UMIN000005762
- Lead Sponsor
- Kenji Watanabe
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)The patient who has internal fistula 2)The patient who is planning to have an operation 3)The patient who is short bowel syndorome 4)The patient of contraindication for adalimumab or Elental 5)The case which is hard to get the patient's consent 6)The patient who was judged for unsuitable by responsibility doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method